These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17265049)

  • 41. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
    Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
    J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microarray analysis reveals differential gene expression patterns in tumors of the pineal region.
    Fèvre-Montange M; Champier J; Szathmari A; Wierinckx A; Mottolese C; Guyotat J; Figarella-Branger D; Jouvet A; Lachuer J
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):675-84. PubMed ID: 16825954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
    Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
    Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.
    Rodriguez FJ; Scheithauer BW; Robbins PD; Burger PC; Hessler RB; Perry A; Abell-Aleff PC; Mierau GW
    Acta Neuropathol; 2007 Mar; 113(3):313-24. PubMed ID: 17061076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
    Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
    Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
    Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
    Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
    J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA ploidy and nuclear morphometry in adult intracranial ependymomas.
    Onguru O; Ulutin C; Celasun B; Gunhan O
    Clin Neuropathol; 2003; 22(6):266-72. PubMed ID: 14672504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric ependymomas: will molecular biology change patient management?
    Grill J; Bergthold G; Ferreira C
    Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgery for spinal cord ependymomas: outcome and prognostic factors.
    Boström A; von Lehe M; Hartmann W; Pietsch T; Feuss M; Boström JP; Schramm J; Simon M
    Neurosurgery; 2011 Feb; 68(2):302-8; discussion 309. PubMed ID: 21135741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracranial ependymoma: factors affecting outcome.
    Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
    Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intracranial ependymomas].
    Gelabert González M; García Allut A; Fernández Villa JM; González García J; Martínez Rumbo R
    Rev Neurol; 2001 Nov 16-30; 33(10):980-6. PubMed ID: 11785014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of squash smear cytology of ependymomas.
    Manasa PL; Uppin MS; Sundaram C
    Acta Cytol; 2012; 56(2):183-8. PubMed ID: 22378082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ependymomas in children express the multidrug resistance gene: immunohistochemical and molecular biologic study.
    Chou PM; Barquin N; Gonzalez-Crussi F; Ridaura Sanz C; Tomita T; Reyes-Mugica M
    Pediatr Pathol Lab Med; 1996; 16(4):551-61. PubMed ID: 9025853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profiles of nasal polyps associated with allergic rhinitis.
    Wu J; Bing L; Jin H; Jingping F
    Am J Otolaryngol; 2009; 30(1):24-32. PubMed ID: 19027509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.